Johns Hopkins HIV Guide
Nelfinavir
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 11, 2025
Citation
, Kathryn Dzintars, Pharm.D., BCPS, and Paul G Auwaerter. "Nelfinavir." Johns Hopkins HIV Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545144/6/Nelfinavir.
K, Auwaerter PG. Nelfinavir. Johns Hopkins HIV Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545144/6/Nelfinavir. Accessed October 31, 2025.
, K., & Auwaerter, P. G. (2025). Nelfinavir. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545144/6/Nelfinavir
K, Auwaerter PG. Nelfinavir [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2025. [cited 2025 October 31]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545144/6/Nelfinavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nelfinavir
ID - 545144
A1 - ,Kathryn Dzintars, Pharm.D., BCPS,
AU - Auwaerter,Paul,M.D.
Y1 - 2025/01/11/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545144/6/Nelfinavir
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
